Compare biologic and targeted therapies for moderate-to-severe Crohn's disease. TNF inhibitors were the first biologics for Crohn's; newer options include IL-23 inhibitors, integrin inhibitors, and JAK inhibitors.
Select any two to compare side by side
Denied one of these medications?
Ellen can decode your denial letter, identify why you were denied, and generate a personalized appeal — free.